Dr. Mike Lappin graduated from Oklahoma State University, then
  completed a rotating internship in small animal medicine and  
  surgery at the University of Georgia. After 2 years in small animal 
  practice in Los Angeles, he returned to the University of Georgia, 
 where he completed a small animal internal medicine residency
 and a PhD in parasitology. Board certified by the American College  
 of  Veterinary Internal Medicine, he is a professor of infectious 
 disease in the Department of Clinical Sciences at Colorado State   
 University College of Veterinary Medicine and Biomedical Sciences.
 Dr. Lappin’s laboratory studies immune responses to vaccination against respiratory viruses in cats, as well as immune responses to feline vaccines.
He also oversees a large diagnostic service for feline infectious agents. In addition to his other responsibilities, Dr. Lappin is director of Shelter Medicine and investigates disease outbreaks and management in shelter settings.

Topic: INFECTIOUS DISEASE PREVENTION: FREQUENTLY ASKED QUESTIONS
Dispel the myths and learn the latest as it pertains to updates in canine and feline preventive medicine. This program will provide answers to the most frequently asked questions about infectious disease. Fact will be separated from fiction regarding vaccines and vector-borne diseases.From feline preventive health visits to new and emerging pathogens in canine infectious respiratory disease complex (CIRDC), this presentation will teach you how to optimize infectious disease diagnosis and prevention with these techniques and tips.
Learning Objectives:
1.Learn how to get more feline patients into your clinic for preventive health visits.
2.Discuss the advantages of using vaccines as a “hook” for physical examination visits.

3.Find out updates regarding flea- and tick-borne diseases, including which agent has the most zoonotic potential and how effective Lyme vaccines really are.
4.Explore optimal infectious disease prevention techniques and tips.
5.Dispel myths about feline vaccines, such as how quickly feline herpesvirus 1 (FHV-1) vaccines induce protection, whether modified-live feline viral rhinotracheitis, calicivirus, and panleukopenia (FVRCP) vaccines affect polymerase chain reaction (PCR) assay results, and how common injection-site sarcomas are.
6.Learn the latest on canine infectious respiratory disease complex (CIRDC), including new and emerging pathogens.

WVVMA SPRING MEETING

Meeting Schedule